Scimeca Dario's Form 4 filing
Precision Biosciences Inc (DTIL) · filed Jan 22, 2025
- Accession no.
- 0000950170-25-008014
- Filed
- Jan 22, 2025
- Trade date
- Jan 20-22, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $42.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Scimeca DarioCIK 0001779581 | Officer (General Counsel and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2025 | Common Stock | MOption exerciseAcquired | +25,312 | – | – | 33,281 | Direct | |
| Jan 22, 2025 | Common Stock | SSaleDisposed | −8,928 | $4.79 | −$42,765.12 | 24,353 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2025 | Common Stock | MOption exerciseDisposed | −1,977 | $0.00 | $0 | 1,978 | Direct | |
| Jan 20, 2025 | Common Stock | MOption exerciseDisposed | −8,427 | $0.00 | $0 | 16,850 | Direct | |
| Jan 20, 2025 | Common Stock | MOption exerciseDisposed | −14,908 | $0.00 | $0 | 29,815 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.